Implanted Synthetic Cells Trigger Tissue Angiogenesis Through De Novo Production of Recombinant Growth Factors

The authors reported that synthetic cells (SCs) genetically encoded to produce proangiogenic factors triggered the physiological process of neovascularization in mice.